Development of antiviral strategies for treatment of chronic hepatitis B

QR Code

Development of antiviral strategies for treatment of chronic hepatitis B

Bibliographic Details
Main Authors:	Seow, Heng Fong, Wang, Suk Mei, Holme, Andrea Lisa, Ali, Manaf
Format:	Monograph
Language:	English
Published:	Research Management Centre 2002
Online Access:	http://psasir.upm.edu.my/id/eprint/29973/ http://psasir.upm.edu.my/id/eprint/29973/1/Development%20of%20Antiviral%20Strategies%20for%20Treatment%20of%20Chronic%20Hepatitis%20B.pdf

Similar Items

Human Hepatitis B Viral Proteins HBX and HBE: Roles in HepG2 Cell Line Survival and Cell Death
by: Holme, Andrea Lisa
Published: (2004)

Establishment Of An In Vitro Cell Culture System For Human Hepatitis B Virus
by: Wang, Suk Mei
Published: (2001)

Detection of hepatitis B surface antigen
by: Tan, Wen Siang, et al.
Published: (2004)

Outcomes after successful direct acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
by: Cheung, Michelle C.M., et al.
Published: (2016)

Cohort study of the impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
by: Foster, Graham R., et al.
Published: (2016)

Reversal of end-stage renal failure using direct-acting antiviral agents for chronic hepatitis C
by: Mitchell, T., et al.
Published: (2016)

Assessment Of Antiviral Usage, Barriers, And Strategies For Scaling Up Hepatitis C Treatment In Malaysia: A Mix Methodology Study
by: Chan, Huan Keat
Published: (2023)

Hepatitis B and C in pregnancy
by: Seow, H.F.
Published: (1999)

Genetic diversity of hepatitis B co-infection with hepatitis C, D and E viruses among Malaysian chronic hepatitis B patients
by: Hudu, Shuaibu Abdullahi, et al.
Published: (2018)

Peptides that inhibit the association of the surface and core antigens of hepatitis B virus
by: Tan, Wen Siang, et al.
Published: (2001)

Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7
by: Tan, Geok Hun, et al.
Published: (2005)

Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia
by: Hellard, M., et al.
Published: (2012)

A Phage – Displayed Cyclic Peptide That Interacts Tightly With the Immunodominant Region of Hepatitis B Surface Antigen.
by: Wen, Siang Tan, et al.
Published: (2005)

Hepatic steatosis among chronic hepatitis C infected patients selected for treatment - a retrospective analysis
by: Jaafar, Khairul Azhar, et al.
Published: (2008)

Expression of human cytokine genes associated with chronic Hepatitis B disease progression
by: Hudu, Shuaibu Abdullahi, et al.
Published: (2017)

Novel genetic variants of Hepatitis B Virus in fulminant hepatitis
by: Chook, Jack Bee *, et al.
Published: (2017)

Molecular epidemiology and antiviral resistance characterization of Hepatitis C virus circulating in Africa and Brazil
by: Adeboyejo, Kazeem Adeyinka
Published: (2020)

Canine idiopathic chronic hepatitis
by: Bexfield, Nicholas
Published: (2017)

Selection of high affinity ligands to hepatitis B core antigen from a phage-displayed cyclic peptide library.
by: Ho, Kok Lian, et al.
Published: (2003)

A phage-displayed single chain variable fragment that interacts with hepatitis B core antigen: Library construction, selection and diagnosis
by: Tan, Geok Hun, et al.
Published: (2007)

Establishing the cascade of care for hepatitis C in England-benchmarking to monitor impact of direct acting antivirals
by: Simmons, Ruth, et al.
Published: (2017)

Hepatitis B surface Antigen (HBsAg) levels in chronic hepatitis B patients - a comparison between patients of different ages and their hepatitisBeAntigen (HBeAg) seroconversion status in a prospective cohort
by: Jaafar, Khairul Azhar, et al.
Published: (2015)

Alteration of peripheral blood lymphocytes profile with HBsAg level in chronic hepatitis B infection
by: Hadi, Qabas Naemah, et al.
Published: (2014)

“I'm obviously not dying so it's not something I need to sort out today”: Considering hepatitis C treatment in the era of direct acting antivirals
by: Wright, C., et al.
Published: (2018)

Quantitative hepatitis B e antigen: a better predictor of hepatitis B virus DNA than quantitative hepatitis B surface antigen
by: Hudu, Shuaibu A., et al.
Published: (2018)

An antiviral composition.
by: Abu Bakar, Fatimah, et al.
Published: (2011)

Alteration of Peripheral Blood Lymphocytes (PBLs) profile with HBsAg level in patients with chronic hepatitis B infection
by: Hadi, Qabas Naemah, et al.
Published: (2014)

Alteration of peripheral blood lymphocytes (PBLs) profile with HBsAg Level in patients with chronic Hepatitis B infection
by: Hadi, Qabas Neamah, et al.
Published: (2014)

Prevalence and genotype distribution of hdv virus among chronic hepatitis b carriers in Hospital Universiti Sains Malaysia
by: Hadi, Fathin
Published: (2023)

Improving hepatitis C direct-acting antiviral access and uptake: A role for patient-reported outcomes and lived experience
by: Goutzamanis, S., et al.
Published: (2019)

Using surveillance data to determine treatment rates and outcomes for patients with chronic hepatitis C virus infection
by: Lattimore, Sam, et al.
Published: (2014)

Anti-hepatitis a virus seroprev alence among chronic viral hepatitis B and C HUSM and its association with Cyp3a4*18 polymorhism
by: Noraizal, Che Hamzah
Published: (2012)

Circular antiviral RNA
by: Omar, Abdul Rahman, et al.
Published: (2012)

An antiviral to cure patients
by: Tang, Ashley
Published: (2021)

Genetic variability of Hepatitis B virus
by: Bajunaid, Huda Ahmad
Published: (2013)

Purification of antibodies against hepatitis B.
by: Ling, Tau Chuan, et al.
Published: (2010)

Correlation between the HBsAg level and the peripheral blood lymphocytes profile in chronic Hepatitis B patients from Malaysia
by: Hadi, Qabas Naemah, et al.
Published: (2016)

Correlation between the HBsAg level and the peripheral blood lymphocytes profile in chronic hepatitis B patients from Malaysia
by: Hadi, Qabas Neamah, et al.
Published: (2016)

Community-based provision of direct-acting antiviral therapy for hepatitis C: Study protocol and challenges of a randomized controlled trial
by: Wade, A., et al.
Published: (2018)

Steatohepatitis and fibrosis in chronic Hepatitis C patients: is there any association?
by: Hasmoni, Mohamed Hadzri, et al.
Published: (2011)